Showing results (191-200 of 469) with videos related to

Sort By:
Pageof 47
Journal of Cellular Biochemistry|November 19, 2011
Development, characterization, and applications of a novel estrogen receptor beta monoclonal antibodyXianglin Wu, Malayannan Subramaniam, Vivian Negron, et al.
Cancer & Metabolism|January 31, 2019
The novel function of tumor protein D54 in regulating pyruvate dehydrogenase and metformin cytotoxicity in breast cancerYongxian Zhuang, Reynold C Ly, Carleigh V Frazier, et al.
Cell Research|July 9, 2020
Author Correction: Regulation of sister chromatid cohesion by nuclear PD-L1Jia Yu, Bo Qin, Ann M Moyer, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2023
Clinical and exploratory biomarker findings from the MODUL trial (Cohorts 1, 3 and 4) of biomarker-driven maintenance therapy for metastatic colorectal cancerMichel Ducreux, Josep Tabernero, Axel Grothey, et al.
Mayo Clinic Proceedings|August 4, 2007
A multidisciplinary approach to the management of breast cancer, part 1: prevention and diagnosisSandhya Pruthi, Kathleen R Brandt, Amy C Degnim, et al.
Clinical & Experimental Metastasis|February 16, 2013
Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenograftsAshwani Khurana, Deok Jung-Beom, Xiaoping He, et al.
Breast Cancer Research : BCR|March 12, 2011
Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifenXianglin Wu, Malayannan Subramaniam, Sarah B Grygo, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 18, 2022
Clinical pharmacogenomic testing and reporting: A technical standard of the American College of Medical Genetics and Genomics (ACMG)Marwan K Tayeh, Andrea Gaedigk, Matthew P Goetz, et al.
BMJ Open|September 25, 2021
BESPOKE study protocol: a multicentre, prospective observational study to evaluate the impact of circulating tumour DNA guided therapy on patients with colorectal cancerPashtoon Murtaza Kasi, Sarah Sawyer, Jessica Guilford, et al.
The Oncologist|September 30, 2016
Broad Detection of Alterations Predicted to Confer Lack of Benefit From EGFR Antibodies or Sensitivity to Targeted Therapy in Advanced Colorectal CancerAndrew Rankin, Samuel J Klempner, Rachel Erlich, et al.
Pageof 47